Shanghai - Delayed Quote CNY

Micro-Tech (Nanjing) Co.,Ltd (688029.SS)

70.91 +2.03 (+2.95%)
At close: April 26 at 3:00 PM GMT+8
Key Events
Loading Chart for 688029.SS
DELL
  • Previous Close 68.88
  • Open 70.30
  • Bid 70.91 x --
  • Ask 70.92 x --
  • Day's Range 69.23 - 71.44
  • 52 Week Range 57.83 - 100.80
  • Volume 3,638,823
  • Avg. Volume 2,285,829
  • Market Cap (intraday) 13.32B
  • Beta (5Y Monthly) 0.17
  • PE Ratio (TTM) 25.15
  • EPS (TTM) 2.82
  • Earnings Date --
  • Forward Dividend & Yield 0.55 (0.78%)
  • Ex-Dividend Date Jun 7, 2023
  • 1y Target Est 103.75

Micro-Tech (Nanjing) Co., Ltd. researches, develops, manufactures, and sells minimally invasive medical devices to hospitals and clinics worldwide. It offers micro-tech endoscopy gastroenterology devices, such as biliary (longwire), biliary (shortwire), biopsy, dilation and hemostasis products, EUS, nitinol stents, resection products, retrieval devices, and accessories; and pulmonology products, such as airway stents, biopsy, dilation balloons, retrieval devices, and accessories. The company also offers OEM/ODM services. Micro-Tech (Nanjing) Co., Ltd. was founded in 1999 and is based in Nanjing, China.

www.micro-tech.com.cn

--

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: 688029.SS

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

688029.SS
26.75%
SSE Composite Index
3.82%

1-Year Return

688029.SS
9.37%
SSE Composite Index
5.40%

3-Year Return

688029.SS
53.73%
SSE Composite Index
11.10%

5-Year Return

688029.SS
--
SSE Composite Index
6.99%

Compare To: 688029.SS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 688029.SS

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    13.32B

  • Enterprise Value

    12.08B

  • Trailing P/E

    25.20

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.36

  • Price/Book (mrq)

    3.58

  • Enterprise Value/Revenue

    4.87

  • Enterprise Value/EBITDA

    19.51

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    20.16%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    14.23%

  • Revenue (ttm)

    2.42B

  • Net Income Avi to Common (ttm)

    486.98M

  • Diluted EPS (ttm)

    2.82

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.29B

  • Total Debt/Equity (mrq)

    1.51%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 688029.SS

Analyst Price Targets

101.35
103.75 Average
70.91 Current
106.16 High
 

Fair Value

 

Company Insights: 688029.SS

People Also Watch